PubMed

Tissue factor pathway inhibitor and other endothelium-dependent hemostatic factors in elderly individuals with normal or impaired glucose tolerance and type 2 diabetes.

Leurs PB, Stolk RP, Hamulyak K, Van Oerle R, Grobbee DE, Wolffenbuttel BH.

Diabetes Care. 2002 Aug;25(8):1340-5.PMID: 12145232 [PubMed - indexed for MEDLINE]Related articlesFree article

Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study.

Meigs JB, Mittleman MA, Nathan DM, Tofler GH, Singer DE, Murphy-Sheehy PM, Lipinska I, D'Agostino RB, Wilson PW.

JAMA. 2000 Jan 12;283(2):221-8.PMID: 10634338 [PubMed - indexed for MEDLINE]Related articlesFree article

Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes: the Framingham Offspring Study.

Meigs JB, O'donnell CJ, Tofler GH, Benjamin EJ, Fox CS, Lipinska I, Nathan DM, Sullivan LM, D'Agostino RB, Wilson PW.

Diabetes. 2006 Feb;55(2):530-7.PMID: 16443791 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison of skin microvascular reactivity with hemostatic markers of endothelial dysfunction and damage in type 2 diabetes.

Beer S, Feihl F, Ruiz J, Juhan-Vague I, Aillaud MF, Wetzel SG, Liaudet L, Gaillard RC, Waeber B.

Vasc Health Risk Manag. 2008;4(6):1449-58.PMID: 19337558 [PubMed - indexed for MEDLINE]Related articlesFree article

Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes.

Caballero AE, Arora S, Saouaf R, Lim SC, Smakowski P, Park JY, King GL, LoGerfo FW, Horton ES, Veves A.

Diabetes. 1999 Sep;48(9):1856-62.PMID: 10480619 [PubMed - indexed for MEDLINE]Related articlesFree article

Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients: lack of association with plasma insulin levels.

Gürlek A, Bayraktar M, Kirazli S.

Diabetes Care. 2000 Jan;23(1):88-92.PMID: 10857975 [PubMed - indexed for MEDLINE]Related articlesFree article

Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.

Petersen KR.

Dan Med Bull. 2002 Feb;49(1):43-60. Review.PMID: 11894723 [PubMed - indexed for MEDLINE]Related articles

[Predictors of abnormal glucose tolerance in persons at risk of type 2 diabetes: the RIAD study]

Henkel E, Köhler C, Temelkova-Kurktschiev T, Hanefeld M.

Dtsch Med Wochenschr. 2002 May 3;127(18):953-7. German. PMID: 11987015 [PubMed - indexed for MEDLINE]Related articles

Plasma levels of free and total TFPI, relationship with cardiovascular risk factors and endothelial cell markers.

Morange PE, Renucci JF, Charles MA, Aillaud MF, Giraud F, Grimaux M, Juhan-Vague I.

Thromb Haemost. 2001 Jun;85(6):999-1003.PMID: 11434709 [PubMed - indexed for MEDLINE]Related articles

Blood coagulation and fibrinolysis in patients with acromegaly: increased plasminogen activator inhibitor-1 (PAI-1), decreased tissue factor pathway inhibitor (TFPI), and an inverse correlation between growth hormone and TFPI.

Erem C, Nuhoglu I, Kocak M, Yilmaz M, Sipahi ST, Ucuncu O, Ersoz HO.

Endocrine. 2008 Jun;33(3):270-6.PMID: 19016004 [PubMed - indexed for MEDLINE]Related articles

Insulin resistance and endothelial dysfunction in type 2 diabetes patients with or without microalbuminuria.

Yu Y, Suo L, Yu H, Wang C, Tang H.

Diabetes Res Clin Pract. 2004 Aug;65(2):95-104.PMID: 15223221 [PubMed - indexed for MEDLINE]Related articles

Tissue plasminogen activator, von Willebrand factor, and risk of type 2 diabetes in older men.

Wannamethee SG, Sattar N, Rumley A, Whincup PH, Lennon L, Lowe GD.

Diabetes Care. 2008 May;31(5):995-1000. Epub 2008 Jan 30.PMID: 18235054 [PubMed - indexed for MEDLINE]Related articlesFree article

Endothelial haemostatic markers in members of families with familial combined hyperlipidemia.

Karásek D, Vaverková H, Halenka M, Slavík L, Novotný D.

Thromb Res. 2009;123(3):466-75. Epub 2008 Apr 16.PMID: 18417194 [PubMed - indexed for MEDLINE]Related articles

Plasminogen activator inhibitor (PAI-1) activity is elevated in Asian and Caucasian subjects with non-insulin-dependent (type 2) diabetes but not in those with impaired glucose tolerance (IGT) or non-diabetic Asians.

Nagi DK, Mohamed Ali V, Jain SK, Walji S, Yudkin JS.

Diabet Med. 1996 Jan;13(1):59-64.PMID: 8741814 [PubMed - indexed for MEDLINE]Related articles

Glucagon as a determinant of fibrinolytic activity in men with different stages of glucose tolerance: impact of glucagon on fibrinolysis.

Henkel E, Gallo S, Siegert G, Koehler C, Hanefeld M.

Blood Coagul Fibrinolysis. 2007 Jun;18(4):327-34.PMID: 17473573 [PubMed - indexed for MEDLINE]Related articles

Fibrinolytic dysfunction after gestation is associated to components of insulin resistance and early type 2 diabetes in latino women with previous gestational diabetes.

Morimitsu LK, Fusaro AS, Sanchez VH, Hagemann CC, Bertini AM, Dib SA.

Diabetes Res Clin Pract. 2007 Dec;78(3):340-8. Epub 2007 Jun 4.PMID: 17544539 [PubMed - indexed for MEDLINE]Related articles

Impaired release of tissue plasminogen activator from the endothelium in Graves' disease - indicator of endothelial dysfunction and reduced fibrinolytic capacity.

Li Y, Chen H, Tan J, Wang X, Liang H, Sun X.

Eur J Clin Invest. 1998 Dec;28(12):1050-4.PMID: 9893018 [PubMed - indexed for MEDLINE]Related articles

Normalisation of tissue factor pathway inhibitor activity after glycaemic control optimisation in type 1 diabetic patients.

Rigla M, Mateo J, Fontcuberta J, Souto JC, de Leiva A, Pérez A.

Thromb Haemost. 2000 Aug;84(2):223-7.PMID: 10959693 [PubMed - indexed for MEDLINE]Related articles

Acute hyperglycemia alters von Willebrand factor but not the fibrinolytic system in elderly subjects with normal or impaired glucose tolerance.

Coppola L, Coppola A, Grassia A, Mastrolorenzo L, Lettieri B, De Lucia D, De Nanzio A, Gombos G.

Blood Coagul Fibrinolysis. 2004 Oct;15(8):629-35.PMID: 15613917 [PubMed - indexed for MEDLINE]Related articles

Fibrinolytic dysfunction in insulin-resistant women with previous gestational diabetes.

Farhan S, Winzer C, Tura A, Quehenberger P, Bieglmaier C, Wagner OF, Huber K, Waldhäusl W, Pacini G, Kautzky-Willer A.

Eur J Clin Invest. 2006 May;36(5):345-52.PMID: 16634839 [PubMed - indexed for MEDLINE]Related articles